EP2756061A4 - COMPOSITIONS FOR SOLUBILIZING CELLS AND / OR TISSUE - Google Patents

COMPOSITIONS FOR SOLUBILIZING CELLS AND / OR TISSUE

Info

Publication number
EP2756061A4
EP2756061A4 EP12876815.7A EP12876815A EP2756061A4 EP 2756061 A4 EP2756061 A4 EP 2756061A4 EP 12876815 A EP12876815 A EP 12876815A EP 2756061 A4 EP2756061 A4 EP 2756061A4
Authority
EP
European Patent Office
Prior art keywords
tissue
compositions
solubilizing cells
solubilizing
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12876815.7A
Other languages
German (de)
French (fr)
Other versions
EP2756061A1 (en
Inventor
Byeong Hee Hwang
Samir Mitragotri
Russell M Lebovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to EP16161790.7A priority Critical patent/EP3056559B1/en
Publication of EP2756061A1 publication Critical patent/EP2756061A1/en
Publication of EP2756061A4 publication Critical patent/EP2756061A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP12876815.7A 2012-05-16 2012-05-16 COMPOSITIONS FOR SOLUBILIZING CELLS AND / OR TISSUE Withdrawn EP2756061A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16161790.7A EP3056559B1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/038169 WO2013172832A1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP16161790.7A Division EP3056559B1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Publications (2)

Publication Number Publication Date
EP2756061A1 EP2756061A1 (en) 2014-07-23
EP2756061A4 true EP2756061A4 (en) 2014-08-13

Family

ID=49584087

Family Applications (2)

Application Number Title Priority Date Filing Date
EP12876815.7A Withdrawn EP2756061A4 (en) 2012-05-16 2012-05-16 COMPOSITIONS FOR SOLUBILIZING CELLS AND / OR TISSUE
EP16161790.7A Active EP3056559B1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP16161790.7A Active EP3056559B1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Country Status (10)

Country Link
EP (2) EP2756061A4 (en)
JP (1) JP2015528691A (en)
KR (1) KR102099487B1 (en)
CN (1) CN104520418A (en)
AU (2) AU2012380348B2 (en)
BR (1) BR112014028239B1 (en)
CA (1) CA2873707A1 (en)
IN (1) IN2014MN02536A (en)
MX (1) MX369625B (en)
WO (1) WO2013172832A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006026248A1 (en) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
US20070183936A1 (en) * 2003-08-01 2007-08-09 Newsam John M Apparatus and methods for evaluating the barrier properties of a membrane
WO2010093861A2 (en) * 2009-02-13 2010-08-19 The Regents Of The University Of Calfornia System, method and device for tissue-based diagnosis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5358492A (en) * 1976-11-08 1978-05-26 Kao Corp Anti-foggig agent composition with lng lasting effect
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
WO1998017315A2 (en) * 1996-10-24 1998-04-30 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
EP1801591B1 (en) * 1997-08-04 2016-12-28 Advanced Life Science Institute, Inc. Methods for detection or measurement of viruses
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
FR2848848B1 (en) * 2002-12-19 2005-01-28 Oreal COMPOSITION FOR WASHING KERATINIC MATERIALS BASED ON AMPHOTERIC SURFACTANT AND PEG MODIFIED BY A HYDROPHOBIC GROUP
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
MXPA06007635A (en) * 2003-12-30 2007-01-30 Wyeth Corp Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability.
JP4422550B2 (en) * 2004-05-25 2010-02-24 日華化学株式会社 Method for producing hydrophilic fluororesin particles
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
WO2009131995A1 (en) * 2008-04-21 2009-10-29 Nanobio Corporation Nanoemulsion influenza vaccine
JP2011518844A (en) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション Nanoemulsions for treating fungal, yeast and filamentous fungal infections
US7700530B2 (en) * 2008-06-30 2010-04-20 Kimberly Clark Worldwide, Inc. Polysensorial personal care cleanser comprising a quaternary silicone surfactant
JP5382687B2 (en) * 2008-11-12 2014-01-08 独立行政法人産業技術総合研究所 Composition and method for suppressing decrease in luminescence intensity in luciferin-luciferase reaction
US20100226983A1 (en) * 2009-01-28 2010-09-09 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070183936A1 (en) * 2003-08-01 2007-08-09 Newsam John M Apparatus and methods for evaluating the barrier properties of a membrane
WO2006026248A1 (en) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
WO2010093861A2 (en) * 2009-02-13 2010-08-19 The Regents Of The University Of Calfornia System, method and device for tissue-based diagnosis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUANG ET AL: "Separation and measurement of desmosine and isodesmosine in vascular tissue hydrolysates by micellar electrokinetic capillary chromatography with a mixed micelle system", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, vol. 1175, no. 2, 4 November 2007 (2007-11-04), pages 294 - 296, XP022373514, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2007.10.091 *
S. PALIWAL ET AL: "One-step acquisition of functional biomolecules from tissues", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 107, no. 33, 17 August 2010 (2010-08-17), pages 14627 - 14632, XP055124735, ISSN: 0027-8424, DOI: 10.1073/pnas.1004302107 *
See also references of WO2013172832A1 *

Also Published As

Publication number Publication date
EP2756061A1 (en) 2014-07-23
CN104520418A (en) 2015-04-15
BR112014028239A2 (en) 2017-06-27
EP3056559A3 (en) 2016-10-12
AU2017203389A1 (en) 2017-06-08
MX2014013794A (en) 2015-04-08
BR112014028239B1 (en) 2021-05-11
EP3056559A2 (en) 2016-08-17
WO2013172832A1 (en) 2013-11-21
EP3056559B1 (en) 2019-07-10
MX369625B (en) 2019-11-14
JP2015528691A (en) 2015-10-01
AU2012380348A1 (en) 2015-01-22
CA2873707A1 (en) 2013-11-21
IN2014MN02536A (en) 2015-09-04
KR102099487B1 (en) 2020-04-09
AU2012380348B2 (en) 2017-02-23
KR20150023394A (en) 2015-03-05

Similar Documents

Publication Publication Date Title
DK2771041T3 (en) Compositions and their use in bone healing
EP2814429A4 (en) METHODS AND APPARATUS FOR COOPERATING VALVE PROSTHESIS WITH TISSUE
CO6930321A2 (en) Tissue healing
HRP20181628T1 (en) COMPOUNDS AND PROCEDURES FOR THEIR USE
SG10202009963PA (en) Melanin modification compositions and methods of use
PL3578201T3 (en) METHODS AND COMPOSITIONS FOR NATURAL CYTOTOXIC CELLS
EP4005507C0 (en) IMPLANT AND GUIDE
EP3190186C0 (en) EXPRESSION OF MIRNAS IN PLACENTA TISSUE
EP2596741A4 (en) ENDOSCOPE, AND TREATMENT INSTRUMENT FOR ENDOSCOPE
BR112014031820A2 (en) polythether adduct and composition
IN2014DN11201A (en)
BR112015007861A2 (en) tissue prosthesis
PL2830654T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION
BR112014014004A2 (en) methods and compositions for reducing body fat and adipocytes
EP2931324A4 (en) COMPOSITIONS AND METHODS FOR TISSUE REGENERATION
BR112015006512A2 (en) composition for treating damaged biological tissues
BR112013014826A2 (en) fat composition
ITTO20110641A1 (en) PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS
EP2844161A4 (en) REMOVAL OF BONE TISSUE
ZA201408056B (en) Compositions and methods for the treatment of mucositis
SG10201701025RA (en) Method for maintaining organ or tissue for transplantation use for long period
HRP20170225T1 (en) PHOSPHOPLATINS AND THEIR USE FOR CARCINOMA TREATMENT
IL236823A0 (en) Compositions for use in the treatment of bone defects
HUE038787T2 (en) Tripeptide compositions and their use for treatment of diabetes
PL3400958T3 (en) COMPOSITIONS AND METHODS OF TREATMENT OF CELIAKII

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20140710

RIC1 Information provided on ipc code assigned before grant

Ipc: C11D 1/88 20060101AFI20140704BHEP

Ipc: C07K 1/14 20060101ALI20140704BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HWANG, BYEONG, HEE

Inventor name: LEBOVITZ, RUSSELL, M.

Inventor name: MITRAGOTRI, SAMIR

17Q First examination report despatched

Effective date: 20150616

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161014